Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory Hardy, M; Lecompte, Thomas Pierre; Lessire, S; Dogné, J M; ... Mullier, F 2020
add to browser selection
Chronic intraocular inflammation as a risk factor for XEN gel stent occlusion: a case of microscopic examination of a fibrin-obstructed XEN stent Gillmann, Kevin; Mansouri, Kaweh; Bravetti, Giorgio Enrico; Mermoud, André 2018
add to browser selection
Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release) Galanakis, D. K.; Neerman Arbez, Marguerite; Kudryk, Bohdan; Henschen, Agnes 2010
add to browser selection
"Heparinization" and hyperfibrinogenolysis by wasp sting Lombardini, Cristina; Helia, Robert-Ebadi; Boehlen, Françoise; Merlani, Paolo 2009
add to browser selection
Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1 Zollner, Thomas Matthias; Veraart, J. C.; Wolter, Manfred; Hesse, S.; ... Kaufmann, Roland 1997
add to browser selection
Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors Montesano, Roberto; Pepper, Michael Sean; Vassalli, Jean-Dominique; Orci, Lelio 1987
add to browser selection
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages Vassalli, Jean-Dominique; Dayer, Jean-Michel; Wohlwend, Annelise Isabelle; Belin, Dominique 1984